Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | -0.29% | 75.84 | 6.0% | $212.45m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -1.83% | 17.72 | 14.1% | $104.27m | |
| CTLT | Catalent, Inc. | -0.65% | 87.60 | 2.2% | $83.69m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.21% | 126.35 | 2.4% | $76.78m | |
| BHC | Bausch Health Cos., Inc. | -1.83% | 17.72 | 0.0% | $76.42m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | -3.45% | 1.12 | 0.5% | $57.30m | |
| PRGO | Perrigo Co. Plc | 2.52% | 51.72 | 6.8% | $48.00m | |
| GWPH | GW Pharmaceuticals Plc | 4.19% | 113.95 | 6.2% | $47.92m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 8.37% | 52.83 | 16.8% | $45.49m | |
| ARGX | argenx SE | -1.10% | 228.22 | 0.0% | $42.94m | |
| AMRN | Amarin Corp. Plc | -0.14% | 6.99 | 1.5% | $42.06m | |
| VRNA | Verona Pharma Plc | 8.56% | 8.50 | 0.0% | $41.91m | |
| PCRX | Pacira Biosciences, Inc. | 4.52% | 60.99 | 10.3% | $41.80m | |
| ICLR | ICON plc | 0.13% | 190.16 | 4.3% | $41.27m | |
| MYOK | MyoKardia, Inc. | 1.23% | 104.67 | 1.8% | $39.78m |
Company Profile
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.